Reply to letter to editor by McCullough

Ann Med. 2021 Dec;53(1):335-336. doi: 10.1080/07853890.2021.1878273.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • COVID-19 Drug Treatment*
  • Humans
  • Hydroxychloroquine*
  • SARS-CoV-2

Substances

  • Hydroxychloroquine